EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nucleotide/Nucleoside Reverse Transcriptase Inhibitor‐Based HIV cART Regimens Produce Mixed Metabolic Responses in Diet‐Induced Prediabetic and Nonprediabetic Sprague Dawley Rats

Amogelang Sedibe iD, Khanyisa Maswanganyi iD, Ntethelelo Sibiya iD, Trevor Nyakudya iD, Mlindeli Gamede iD

BioMed Research International · 2026-01 · 2026 (1)

DOI: 10.1155/bmri/9557266 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioMed Research International, online erschienen am 10.11.2026. Verfasst von Amogelang Sedibe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Health Sciences, University of Pretoria, Pretoria, Gauteng, South Africa, up.ac.za. Hauptthemen laut MEDLINE: Prediabetic State, Reverse Transcriptase Inhibitors, Anti-HIV Agents, HIV Infections. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: South African Medical Research Council, National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The rise in HIV prevalence has led to more individuals using antiretroviral therapy (ART). These drugs, together with concurrent lifestyle factors, contribute to metabolic dysfunction, such as an increased risk of prediabetes. The asymptomatic nature of prediabetes may increase the probability of initiating ART without appropriate individualised regimen selection or required metabolic monitoring.

Objectives

This study evaluated the effects of NRTI‐ and NNRTI‐based fixed‐dose combination regimens used as pre‐exposure prophylaxis (Truvada) and for HIV management (Triovir) on selected markers of glucose homeostasis.

Methods

Forty‐two male Sprague Dawley rats (150–180 g) were randomly allocated into two main groups: nonprediabetic (NPD) ( n = 21) and prediabetic (PD) ( n = 21). Prediabetes was induced using a high‐fat, high‐carbohydrate (HFHC) diet over 20 weeks, followed by a treatment period lasting 12 weeks. Treatment procedure: the NPD and PD rats were further randomly subdivided into their respective ART regimens ( n = 7/group). After the treatment period, the study was terminated, and tissues and organs of interest were collected for biochemical analyses.

Results

HFHC feeding effectively induced a PD phenotype, characterised by elevated fasting glucose, glucose intolerance, increased homeostasis model assessment of insulin resistance (HOMA‐IR), hypertriglyceridaemia and weight gain ( p < 0.05). Treatment with Truvada and Triovir attenuated these metabolic markers in PD and NPD groups. However, HOMA‐IR was elevated in NPD animals following both treatments. The administration of either regimen in NPD animals increased plasma C‐peptide levels, whereas plasma glucagon remained unchanged. In PD animals, Truvada treatment increased C‐peptide concentrations, whereas Triovir reduced them. Hepatic glucose exhibited a pattern comparable with the C‐peptide response in NPD animals. However, in PD groups, both treatments lowered glucagon levels and elevated hepatic glucose concentrations.

Conclusion

Truvada and Triovir caused mixed responses on metabolic dysfunction in diet‐induced PD rats. These findings highlight the complex metabolic interactions of ART, warranting further mechanistic studies, particularly in populations on ART with pre‐existing metabolic risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prediabetic StateReverse Transcriptase InhibitorsAnti-HIV AgentsHIV InfectionsNucleotidesAnimalsMaleRats, Sprague-DawleyRatsBlood GlucoseDiet, High-Fat

Stichwörter der Autor:innen

HIV-antiretroviral therapyHIV-fixed-dose combination therapyType 2 diabetes mellitusWestern lifestyledrug-metabolic complicationspancreatic health outcomesprediabetes

Substanzen

Reverse Transcriptase InhibitorsBlood GlucoseAnti-HIV AgentsNucleotides

Autor:innen und Institutionen

  • Department of Physiology, Faculty of Health Sciences, University of Pretoria, Pretoria, Gauteng, South Africa, up.ac.za.
  • Pharmacology Division, Faculty of Pharmacy, Rhodes University, Makhanda, Eastern Cape, South Africa, ru.ac.za.

ORCID-Profile: Amogelang Sedibe, Khanyisa Maswanganyi, Ntethelelo Sibiya, Trevor Nyakudya, Mlindeli Gamede

Förderung

  • South African Medical Research Council
  • National Research Foundation

Zitieren

APA

Sedibe, A., Maswanganyi, K., Sibiya, N., Nyakudya, T., & Gamede, M. (2026). Nucleotide/Nucleoside Reverse Transcriptase Inhibitor‐Based HIV cART Regimens Produce Mixed Metabolic Responses in Diet‐Induced Prediabetic and Nonprediabetic Sprague Dawley Rats. BioMed Research International, 2026(1). https://doi.org/10.1155/bmri/9557266

Vancouver

Sedibe A, Maswanganyi K, Sibiya N, Nyakudya T, Gamede M. Nucleotide/Nucleoside Reverse Transcriptase Inhibitor‐Based HIV cART Regimens Produce Mixed Metabolic Responses in Diet‐Induced Prediabetic and Nonprediabetic Sprague Dawley Rats. BioMed Research International. 2026;2026(1). doi:10.1155/bmri/9557266

BibTeX
@article{Sedibe2026,
  author = {Sedibe, Amogelang and Maswanganyi, Khanyisa and Sibiya, Ntethelelo and Nyakudya, Trevor and Gamede, Mlindeli},
  title = {Nucleotide/Nucleoside Reverse Transcriptase Inhibitor‐Based HIV cART Regimens Produce Mixed Metabolic Responses in Diet‐Induced Prediabetic and Nonprediabetic Sprague Dawley Rats},
  journal = {BioMed Research International},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/bmri/9557266}
}
Kostenlos starten →